TICRR and papillary renal cell carcinoma: Consistent with this, broader literature links TICRR overexpression to adverse outcomes in other cancers (e.g., endometrial and papillary renal cell carcinoma) and to cell-cycle/replication control, underscoring the generalizability of our findings (19, 20).